ISSN: 1389-2002

Journal Home

Journal Guideline

Current Drug Metabolism Q3 Unclaimed

Bentham Science Publishers B.V. Netherlands

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Current Drug Metabolism is a journal indexed in SJR in Pharmacology and Clinical Biochemistry with an H index of 122. It has a price of 2480 €. It has an SJR impact factor of 0,453 and it has a best quartile of Q3. It is published in English. It has an SJR impact factor of 0,453.

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Clinical Biochemistry (Q3) Pharmacology (Q3)

Price

2480 €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

0,453

SJR Impact factor

122

H Index

69

Total Docs (Last Year)

312

Total Docs (3 years)

5722

Total Refs

643

Total Cites (3 years)

287

Citable Docs (3 years)

2.08

Cites/Doc (2 years)

82.93

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Journal of Toxicology Q3
Journal of Antibiotics Q3
Human Psychopharmacology Q3
Current molecular pharmacology Q3
Journal of Physiology and Pharmacology Q3

Compare this journals

Aims and Scope

Best articles by citations

Expression and Function of Cytochrome P450 in Brain Drug Metabolism

Assessment of miR-212 and Other Biomarkers in the Diagnosis and Treatment of HBV-infection-related Liver Diseases

A Novel PCR-RFLP Method for Detection of POR*28 Polymorphism and its Genotype/Allele Frequencies in a Turkish Population

The Prediction of Human Intestinal Absorption Based on the Molecular Structure

Pharmacokinetic Mechanisms for Reduced Toxicity of Irinotecan by Coadministered Thalidomide

Interaction of Drug or Food with Drug Transporters in Intestine and Liver

Influence of the OATP Polymorphism on the Population Pharmacokinetics of Methotrexate in Chinese Patients

Molecular Design of Peptide-Fc Fusion Drugs

Variation of Drug Kinetics in Pregnancy

Disposition of Drugs of Abuse and Their Metabolites in Wastewater as a Method of the Estimation of Drug Consumption

Effect of the NMDA-Receptor Antagonist Dextromethorphan in Infant Rat Pneumococcal Meningitis

Artificial Membrane Assays to Assess Permeability

SHOW MORE ARTICLES

Current Designs and Developments of Fucoidan-based Formulations for Cancer Therapy

Cytochrome P450 Expression in the Liver of Food-Producing Animals

Acknowledgements to Reviewers:

The Role of Metabonomics at the Interface Between Drug Metabolism and Safety Assessment

Metabolic Stability: Main Enzymes Involved and Best Tools To Assess It

Author Index To Volume 7

Has the time come to employ population and individual bioequivalence for the evaluation of generics?

Mechanism-Based Inactivation of Cytochrome P450 Enzymes: Chemical Mechanisms, Structure-Activity Relationships and Relationship to Clinical Drug-Drug Interactions and Idiosyncratic Adverse Drug Reactions

Meet Our Editorial Board Member:

Using Measured pKa, LogP and Solubility to Investigate Supersaturation and Predict BCS Class

Nanotherapeutics for the Treatment of Cancer and Arthritis

The Modulating Effects of Endogenous Substances on Drug Metabolising Enzymes and Implications for Inter-Individual Variability and Quantitative Prediction